RS Momentum (Rate of Change) now uses a static base date for more consistent and comparable results. Users can set a custom base date via the new BASE_DATE option (ISO format date). If not provided, ...

Prince earns his first hit on four Billboard charts nearly a decade after his death after "Purple Rain" was featured in the final season of Stranger Things. DENVER, CO – NOVEMBER 3: Prince Rogers ...

Developer A&R Atelier announced "several new Ecco the Dolphin products and games" are in development. A&R Atelier was founded by the original creators of Ecco the Dolphin in Half Moon Bay, California.

Stage 3 multiple myeloma is defined by high beta-2 microglobulin, elevated LDH, and high-risk genetic abnormalities. Diagnosis involves CRAB criteria and tests like bone marrow biopsy, imaging, and ...

Meta is planning to lay off about 10 percent of staff in its Reality Labs division, which includes the Oculus Studios division that runs first-party game development studios. This is according to The ...

It was one Christmas visitor that didn’t overstay its welcome. A Burmese python that had been spotted in a Miami-Dade neighborhood was removed just days before Christmas after a resident out for a ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Brent D. Griffiths Every time Brent D. Griffiths publishes a story, you’ll get an alert ...

In October, the music industry trade bible Billboard changed its rules for inclusion on the Hot 100, its cross-genre charting of US music consumption. This has happened in the past; when the chart ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

The Colts were dealt a brutal blow on Sunday when Daniel Jones went down with an Achilles injury during the team’s Week 14 game against the Jaguars. With just a few weeks to go until the playoffs, and ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...